Analysis and Evaluation of the Drug Use on Inpatients with Cerebral Infarction Based on Guideline and Clinical Pathway

WANG Na,ZHAO Rong-sheng,SUN Lu-lu,YU Tong
DOI: https://doi.org/10.13699/j.cnki.1001-6821.2014.07.022
2014-01-01
Abstract:Objective To analyze and evaluate the drug use on inpa-tients with cerebral infarction ( CI ).Methods By retrospective study method , the analysis of drug use on inpatients with CI , and evaluation of rationality of drug use based on the guidelines and clinical pathway of pa-tients with CI were carried out.Results Drugs or the treatment of CI accounted for 56.49%of all drugs ,and the top three are cerebrovascular medicine , anti-platelet agents and Chinese medicine preparations.Five types of national guidelines recommendations on CI drugs showed disa-greement,for example, insulin and anti-platelet agent etc.The national essential drugs for the treatment of CI in our hospital accounted for 40.27%, and the average cost of medicine was up to 10 000 yuan, accounting for about 50%of the total cost.84%of the medication was in accord with guidelines and clinical pathways.Conclusion The rationa-lity of some drugs for the treatment of CI lacks support from evidence -based medicine.
What problem does this paper attempt to address?